Cardiovascular disease among people living with HIV in Brazil.

Abstract

There is a paucity of data on cardiovascular disease (CVD) among people living with HIV (PLHIV) in resource-limited countries. We assessed factors associated with CVD and the impact of prevalent CVD on all-cause mortality in PLHIV on antiretroviral therapy in Brazil. Competing risk regression to assess factors associated with CVD and all-cause mortality in the HIV-Brazil Cohort Study between 2003 and 2014. Among 5614 patients, the rate of CVD was 3.5 (95% confidence interval [95% CI] 2.9-4.3) per 1000 person-years. CVD was associated with older age (adjusted hazard ratio [aHR] 6.4 for ≥55years vs. <35years, 95% CI: 2.5-16.3, P<0.01), black race (aHR 1.8 vs. white race, 95% CI: 1.0-3.1, P=0.04), past CVD (aHR 3.0 vs. no past CVD, 95% CI: 1.4-6.2, P<0.01), hypertension (aHR 1.8 vs. no hypertension, 95% CI: 1.0-3.1, P=0.04), high-grade dyslipidemia (aHR 9.3 vs. no high-grade dyslipidemia, 95% CI: 6.0-14.6, P<0.01), ever smoking (aHR 2.4 vs. never, 95% CI: 1.2-5.0, P=0.02) and low nadir CD4 cell count (aHR 1.8 for 100-250cells/mm3 vs. >250cells/mm3 , 95% CI: 1.0-3.2, P=0.05). The rate of death was 16.6 (95% CI: 15.1-18.3) per 1000 person-years. Death was strongly associated with having had a past CVD event (aHR 1.7 vs. no past CVD event, 95% CI: 1.1-2.7, P=0.01). Traditional and HIV-specific factors associated with CVD among PLHIV in Brazil are similar to those identified among PLHIV in high-income countries. PLHIV in Brazil with a history of CVD have a high risk of death. CVD care and treatment remain priorities for PLHIV in Brazil as this population ages and antiretroviral therapy use expands.